Well Beaza, Im happy and sad at the same time.
Sad that we don't have a deal yet and we have had to wait for oh so long
Happy that we have a drug that will address a major unmet need and is so broad acting. It's value goes up literally by the month, especially when we start dosing in the P3. The securing of financing will not only be one of the biggest milestones commercially and from a validation stand point, it will pivot us totally and many doors will eventually open.
My thoughts.
- Forums
- ASX - By Stock
- PAR
- The Ghosh Study - PART 1
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.72%
!
28.5¢

The Ghosh Study - PART 1, page-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $110.0M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 28.0¢ | $32.93K | 115.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 295733 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 59264 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 295733 | 0.280 |
8 | 181089 | 0.275 |
9 | 126393 | 0.270 |
1 | 11206 | 0.265 |
6 | 125401 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 59264 | 4 |
0.295 | 2746 | 1 |
0.300 | 19063 | 3 |
0.310 | 161674 | 5 |
0.315 | 68233 | 4 |
Last trade - 15.21pm 17/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online